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Abstract 
Background: Infectious keratoconjunctivitis (IKC) is a transmissible disease in semi-domesticated Eurasian reindeer 
(Rangifer tarandus tarandus). It is regarded as multifactorial and a single causative pathogen has not yet been identi-
fied. From clinical outbreaks we have previously identified Cervid herpesvirus 2 (CvHV2) and Moraxella bovoculi as 
candidates for experimental investigations. Eighteen reindeer were inoculated in the right eye with CvHV2 (n = 5), M. 
bovoculi (n = 5), CvHV2 and M. bovoculi (n = 5) or sterile saline water (n = 3; controls).
Results: All animals inoculated with CvHv2, alone or in combination with M. bovoculi, showed raised body tempera-
ture, increased lacrimation, conjunctivitis, excretion of pus and periorbital oedema; clinical signs that increased in 
severity from day 2 post inoculation (p.i.) and throughout the experiment, until euthanasia 5–7 days p.i. Examination 
after euthanasia revealed corneal oedema, and three animals displayed a corneal ulcer. CvHV2 could be identified in 
swab samples from both the inoculated eye and the control eye from most animals and time points, indicating a viral 
spread from the inoculation site.
Conclusions: This study showed that CvHV2 alone and in combination with M. bovoculi was able to cause the char-
acteristic clinical signs of IKC in reindeer, whereas inoculation of M. bovoculi alone, originally isolated from a reindeer 
with IKC, did not produce clinical signs. Previous studies have suggested that herding procedures, animal stress and 
subsequent reactivation of latent CvHV2 infection in older animals is a plausible mechanism for IKC outbreaks among 
reindeer calves and young animals in reindeer herds. However, further studies are needed to fully understand the 
infection biology and epidemiology associated with IKC in reindeer.
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Background
Infectious keratoconjunctivitis (IKC) has been reported 
in semi-domesticated Eurasian tundra reindeer (Rangi-
fer tarandus tarandus) in Fennoscandia for more than a 
century [1], causing outbreaks among calves of the year 
(<1 year) and young animals particularly [2–4]. The first 
sign of the disease is increased lacrimation observed as 
an untidy and miscoloured periocular hair coat followed 
by conjunctivitis and increasing periorbital and corneal 
oedema. The oedema is giving the eye an opaque, and 
whitish to bluish appearance (Fig. 1a), which is how IKC 
is usually recognized in the field by reindeer herders. In 
the absence of spontaneous healing, the infection pro-
gresses with an increasing severity of conjunctivitis and 
oedema, corneal ulceration, and panophthalmitis lead-
ing to permanent blindness (Fig.  1b). For reindeer, that 
spend most of the year free-ranging and unattended, this 
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disease represents an important animal welfare issue as 
well as a potential source of economic loss for the herders 
[2, 4].
In spite of long-term awareness of IKC in reindeer, a 
causative agent has not yet been identified and IKC in 
reindeer is regarded as a multi-factorial disease, similar 
to infectious bovine keratoconjunctivitis (IBK), com-
monly referred to as “pinkeye” in cattle. The Gram-
negative bacterium Moraxella bovis is suggested as the 
causative agent of IBK [5], although recent studies have 
shown that Moraxella bovoculi, originally identified in 
2002 and shown to be distinct from M. bovis, may also be 
associated with IBK [6, 7]. A disease similar to IKC has 
also been documented in sheep and goats [8, 9], as well 
as in a wide range of wild animal species, such as moose 
(Alces alces), mule deer (Odocoileus hemionus), ibex 
(Capra ibex), chamois (Rupicapra rupicapra), roe deer 
(Capreolus capreolus) and red deer (Cervus elaphus). 
Many different infectious agents have been associated 
with the disease in the different species [10–14], of which 
the majority have been bacteria, including known poten-
tial pathogens such as Mycoplasma spp.
Similarly, many different bacteria have been isolated 
from reindeer with IKC, such as M. bovoculi, M. ovis, 
Pasteurella multocida, and Trueperella pyogenes [2–4, 15, 
16]. In a recent study of reindeer in Norway, Sweden and 
Finland, analyses of swab samples from the conjunctiva 
of clinically healthy reindeer and of reindeer with clinical 
IKC, showed that M. bovoculi was the bacterial agent that 
was most prevalent [17].
However, during an outbreak of IKC in reindeer in 
Troms County, Norway, the reindeer alphaherpesvirus, 
cervid herpesvirus 2 (CvHV2), was identified as the pri-
mary infectious agent based on the finding of this virus 
during the early clinical stages of the disease. Bacteria 
such as M. bovoculi seemed to dominate during later 
stages of IKC along with declining virus titers from the 
swab samples of the conjunctiva of affected animals [4].
In addition, environmental factors such as stress asso-
ciated with gathering, corralling, handling and transport, 
reduced body condition or emaciation, exposure to UV 
light, and a dry and dusty environment may impact the 
pathogenesis of IKC in reindeer [2, 18, 19]. During natu-
ral outbreaks of IKC in reindeer, it is difficult to gain an 
overview of which potential pathogens are involved. It is 
also challenging to conduct a controlled sampling regime 
and to register the onset and development of disease. In 
addition, it is difficult to control environmental factors. 
In this study, reindeer calves <1 year old were inoculated 
with CvHV2 and M. bovoculi, which are considered the 
two most relevant candidates for IKC [4, 17]. The aim of 
this study was to investigate if experimental inoculation 
with CvHV2, M. bovoculi, or a combination of the two 
agents, was able to cause clinical IKC in reindeer.
Methods
Animals
Semi-domesticated Eurasian tundra reindeer (n  =  27) 
calves, approximately 11 months old, were gathered from 
their mountain pastures. They were corralled and physi-
cally restrained for ID-tagging (plastic collar) and sam-
pling to check for previous exposure to CvHV2 and M. 
bovoculi. Blood was obtained with a vacutainer system 
from the jugular vein and serum prepared by centrifuga-
tion and stored at −20  °C. For virological investigation, 
sterile cotton swabs were used to sample the conjunc-
tiva bilaterally, the nostrils and the vagina (females). 
Swabs were subsequently placed in 1.8 ml cryotubes with 
800  µl of Eagle’s minimum essential medium (EMEM) 
Fig. 1 Infectious keratoconjunctivitis (IKC) during an outbreak 
among free-ranging Eurasian semi-domesticated tundra reindeer 
(Rangifer tarandus tarandus): a corneal oedema indicated by an 
opaque and discolored cornea. b Severe grade of IKC with panoph-
thalimitis, oedema and haemorrhage. This condition often involves 
corneal ulcer and may lead to permanent blindness
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containing antibiotics (10,000 U/ml penicillin and 10 mg/
ml streptomycin; 1  ml/l of gentamicin, 50  mg/ml and 
10 ml/l of amphotericin B 250 μg/ml; EMEMab 10 ml/l) 
and stored at −80 °C. For bacteriological investigation, a 
swab  (TranswabR, Medical Wire & Equipment, Wiltshire, 
UK) was introduced into both conjunctivae, rubbed gen-
tly against the mucosal lining and placed in its transport 
medium container. Blood samples were tested for anti-
bodies against CvHV2. Swab samples from the conjunc-
tiva and nostrils were tested for the presence of CvHV2 
DNA (nested polymerase chain reaction [PCR]), whereas 
swab samples from conjunctiva were tested for M. 
bovoculi (cultivation), as described below. Based on the 
test results, 21 animals (5 females and 16 males) with no 
indication of previous exposure to CvHV2 or M. bovoculi 
were recruited to the study. The animals were corralled 
together in a fence (see below) for a habituation period 
of four weeks before inoculation. The inoculation experi-
ment lasted for a total of 15 days.
All animals were chemically immobilized and weighed 
twice during the study, i.e. on day 0 (inoculation) and 
on the day of euthanasia. Animals were immobilized 
by darting (Dan-Inject JM Special; Dan-Inject ApS, 
Børkop, Denmark) using a combination of medetomi-
dine  (Zalopine® 10  mg/ml, Orion Corporation Ani-
mal Health, Espoo, Finland) and ketamine  (Ketalar® 
50  mg/ml, Pfizer AS, Oslo, Norway) at a fixed ratio of 
1:5 (mg:mg) medetomidine:ketamine. When the inocu-
lation process was completed, sedation was reversed by 
intramuscular injection of atipamezole (Antisedan™; 
Atipamezole 5 mg/ml, Zoetis, UK) at a fixed ratio of 5:1 
atipamezole:medetomidine and animals were monitored 
until they were standing. Despite using recommended 
drugs and doses being reduced to one-third of those rec-
ommended for semi-domesticated reindeer [20], three 
reindeer (one female, two males) died from acute shock-
like complications. Similar complications did not occur 
during the second round of chemical immobilization 
using the same drugs and doses. When chemically immo-
bilized, body temperature was measured with a digital 
clinical thermometer (Fluke Thermometer 51/52 II; Fluke 
Norge, Oslo, Norway), with a sensor positioned 30  cm 
inside the rectum. Pulse rate and arterial oxyhemoglobin 
 (SpO2) was measured with a handheld pulse oximeter 
(Masimo RAD 57; Masimo International Sàrl, Neuchatel, 
Switzerland) with the clip-sensor applied to the tongue. 
Respiratory rate was recorded by counting breathing 
movements of the chest using a stopwatch.
Animals were euthanized at different time points dur-
ing the experiment using a captive bolt stunning gun 
followed by bleeding of the jugular vein. Animals R19 
(CvHV2-group) and R16 (M. bovoculi group) were eutha-
nized on day 2 and 3 respectively, due to fracture of the 
femur. Animals in the two groups inoculated with CvHV2 
(alone or in combination with M. bovoculi) were eutha-
nized according to defined animal welfare end-points on 
days 3–7 post inoculation (p.i.) (Table 1). Remaining ani-
mals of the M. bovoculi group were euthanized on day 6 
(n = 1) and day 13 (n = 3) p.i., whereas the control ani-
mals (n = 3) were euthanized on day 15 p.i. Animals with 
no other clinical symptoms besides those observed in the 
eyes were sampled in the animal experimental facility, 
whereas animals with trauma and animals that experi-
enced respiratory distress upon chemical immobilization 
were subjected to a full necropsy in an attempt to deter-
mine the cause of these unexpected complications.
Animal facility, feeding and handling
Animals were introduced to an outdoor field research 
facility on May 6th, 2014. The corral consists of one large 
pen (approx. 100 × 80 m) and four smaller pens (approx. 
50 × 50 m), all separated from each other and from the 
surrounding areas by 2.5  m high steel wire fences. The 
ground inside the pens was covered with a deep layer 
of snow in the beginning, but due to snow melting and 
greening in the spring, fresh grass pasture became avail-
able. Animals were ID-tagged with an ear tag and by 
spraying a number on the fur on both sides of the body to 
ensure easy identification. They were corralled together 
for the first four weeks (habituation period) to get used to 
the facility, the feed and the presence of people.
The animals were fed lichen (Cladina spp.), which was 
gradually replaced by commercial pelleted feed for reindeer 
(Reinsdyrfôr, Felleskjøpet, Trondheim, Norway). 1 week 
before inoculation and throughout the remaining experi-
ment, the animals were fed pellets ad libitum, supplemented 
with lichen. Fresh water was provided and changed on a 
daily basis. Body condition, evaluated by visual inspection 
and palpation, varied from medium to lean, but increased 
during the habituation period. On the day of inoculation, 
the animals weighed 37–59  kg (mean 49.1  kg) and were 
separated into four groups without further contact (Control, 
CvHV2, M. bovoculi and CvHV2/M. bovoculi).
During the entire study, the animals were fed and 
inspected three times a day by veterinarians licenced 
for conducting animal experiments. A record was kept 
describing the behaviour of each animal, condition, food 
intake and interactions between animals as well as devel-
opment of clinical signs.
Except for day 0 (inoculation) and on the day of eutha-
nasia at varying time points p.i. when animals were 
chemically immobilized, all other close inspections and 
sampling were conducted during physical restraint. How-
ever, on days when animals were not handled, the evalu-
ation and development of clinical signs was observed at a 
distance of a few metres with binoculars.
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Table 1 Clinical signs from the right eye of 10 semi-domesticated Eurasian tundra reindeer (Rangifer tarandus tarandus) 
after inoculation with cervid herpesvirus 2 (CvHV2; n = 5) or a combination of CvHV2 and Moraxella bovoculi (n = 5) (data 
from animals inoculated with M. bovoculi alone or from control animals are not shown)
Clinical signs are indicated, relative to the day of inoculation (day 0). Observations during day 1, day 3, day 4 and day 6 were conducted without handling the animals, 
whereas all animals were captured (physical restraint) and sampled at day 2 and day 5
The time of euthanasia for each animal is indicated with italic text
a Pus: (1) small amounts (clots), (2) large amounts, and (3) huge amounts of pus, adherent to eyelids/skin and covering the eye
b P-oedema: periorbital oedema: (1) slight swelling of conjunctiva, (2) severe oedema, and (3) extensive oedema, periorbital tissues covering the eyeball
c Euthanized due to trauma
Inoculum ID Day 0 Day 1 Day 2 Day 3 Day 4 Day 5 Day 6 Day 7
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Preparation of inocula
CvHV2 was originally isolated from the conjunctiva of a 
reindeer with clinical IKC [4]. The virus was propagated 
in Madin-Darby bovine kidney (MDBK) cells (ATCC 
CCL22) in EMEM supplemented with 10% horse serum 
(LGC Standards, Middlesex, UK). Virus cultures were 
harvested when more than 90% of the cells showed 
cytopathic effect (CPE). Cellular debris was removed by 
centrifugation (7800g, 30  min) and viral particles in the 
supernatant were pelleted through a 30% sucrose cush-
ion (20,000  g, 1  h), re-suspended in 5  ml PBS, filtered 
through a 0.45  μm cellulose filter (Merck Millipore, 
Darmstadt, Germany) and frozen at −80  °C. The virus 
titre of the inoculum was 5.8 × 106  TCID50/ml.
The M. bovoculi strain used for inoculation was origi-
nally cultivated from a swab sample from the conjunctiva 
of a Norwegian reindeer with clinical IKC in 2014. The 
colonies were 2–3  mm in diameter, yellow/grey, round, 
with a shiny “fat” appearance, and revealed beta-haemol-
ysis after 24 h growth on blood agar. The colonies grew 
at 37  °C, but only in aerobic conditions (without  CO2). 
The bacteria were Gram negative with a coccoid form, 
and the catalase and oxidase tests were positive. Poten-
tial virulence factors were not investigated. The isolate 
was verified as M. bovoculi by 16s rRNA sequencing (data 
not shown). After storage (−80  °C), the isolate was cul-
tivated on 5% sheep blood agar at 37  °C under aerobic 
conditions for 24  h prior to inoculation. The bacterium 
underwent a total of four in vitro passages (from isolation 
to inoculation).
Inoculation
While the animals were sedated, both eyes were pho-
tographed and checked for general clinical signs and 
for corneal ulcers using the fluorescein test (Fluores-
ceinnatrium Minims 20  mg/ml; Chauvin, Surrey, UK). 
Disposable coats and gloves were used by all persons 
involved in the inoculation and sampling of the animals. 
For any intervention with the animals (feeding, inocula-
tion, sampling), the control group was visited before the 
inoculated animals.
Prior to inoculation and at each of the following inspec-
tions, eyes were photographed, sampled (swab) and 
checked for corneal ulcers using fluorescein, followed 
by thorough flushing of the eyes with sterile water. Local 
anaesthesia (Oxibuprokain Minims 4 mg/ml; Chauvin) was 
applied in the right eye 4 min prior to a mild rubbing of the 
conjunctival mucosa with sterile sandpaper (grade 60).
The virus was inoculated by introducing a small ster-
ile cotton cushion, soaked in PBS/CvHV2, to the con-
junctiva under the lower eyelid and keeping it there for 
4 min. M. bovoculi was inoculated by picking a colony of 
M. bovoculi from the agar plate with a sterile cotton stick 
and spreading it onto the rubbed area of the conjunctiva. 
Bacterial colonies from the same plate were subsequently 
reseeded onto new agar plates to check for viability. These 
procedures for viral and bacterial inoculations were con-
ducted to allow access of virus and bacteria in excess to 
slightly scarified mucosal cells of the conjunctiva. When 
inoculating both CvHV2 and M. bovoculi in the same eye, 
the virus was inoculated first, followed by the bacterium 
after 10 min. For the animals in the control group, a ster-
ile cotton stick was soaked in sterile water and applied 
onto the rubbed conjunctiva. The left eye was inspected 
as described above, but not further manipulated, and 
served as a control for each animal (all groups).
Bacterial cultivation
Swab samples from the conjunctiva of both eyes, 
obtained on the day of inoculation (Day 0) and every 
second day after inoculation, were subjected to culti-
vation on a 5% sheep blood agar plate. The plates were 
incubated aerobically at 37 °C and inspected after 24 and 
48 h. Bacterial colonies that were yellow to grey of colour, 
2–3  mm in diameter, with a shiny “fat” appearance and 
were beta-haemolytic, were suspected to be Moraxella 
spp. Such colonies were sub-cultured for purity and fur-
ther characterized (morphology, Gram staining, catalase, 
oxidase). Selected isolates were subsequently identified to 
species level (score > 2) by MALDI-TOF mass spectrom-
etry (Microflex; Bruker UK Limited, Coventry, UK).
DNA extraction, PCR and sequencing
To verify that the animals did not harbour CvHV2 viral 
particles in the conjunctival mucosa prior to the experi-
ment, DNA was extracted from swabs obtained from the 
conjunctival mucosa  (QIAamp® DNA Mini Kit, Hilden, 
Germany) with a mean output of 8.1  ng/µl (SD =  8.0) 
and a nested PCR was conducted as described previously 
[21]. The inner primer set amplified a 294  bp region of 
the UL27 gene encoding glycoprotein B (gB), which is a 
highly conserved gene region among ruminant alphaher-
pesviruses [22]. CvHV2 (strain Salla 82) [23] and BoHV1 
[24] were used as positive controls. PCR amplicons were 
separated by agarose gel electrophoresis and visualized 
with ethidium bromide (Sigma-Aldrich Norway AS, 
Oslo, Norway).
A quantitative real-time Taqman Probe based PCR 
(qPCR), amplifying a 95 bp fragment in a different region 
of the UL27 gene as compared to the nested PCR and 
shown previously to detect Rangiferine herpesvirus (now 
designated CvHV2), was performed as described previ-
ously [25]. The PCR was conducted with two slight modifi-
cations; the annealing temperature was reduced to 58.9 °C 
(following thermal gradient analysis) and the volume of 
nuclease-free water was increased from 4.0 to 4.5 µl for a 
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total reaction volume of 25 µl. Samples were run in dupli-
cates. A positive control (CvHV2, used as inoculum) [4], 
a negative control (DNA extracted from muscular tissue 
of a CvHV2 seronegative control animal), and a non-tem-
plate control containing all PCR-components except DNA 
were included on each plate. This technique was used to 
analyse all eye swab and plasma samples collected from 
day 0 and throughout the experiment.
PCR amplicons were prepared for nucleotide sequenc-
ing by enzymatic removal of unused dNTP and primers 
(ExoSAP-IT™; Amersham Pharmacia Biotech, Sweden), 
after which sequencing was conducted  (BigDye® Ter-
minator v3.1 cycle sequencing kit; Applied Biosystems, 
Norway) in an Applied Biosystems 3130 XL Genetic 
Analyzer (Applied Biosystems).
Serology
Serum samples were investigated for anti-alphaherpesvi-
rus antibodies using a commercial bovine enzyme-linked 
immunosorbent assay (ELISA; gB Blocking, LSI Labo-
ratoire Service International, Lissieu, France) based on 
BoHV1 glycoprotein B (gB) as an antigen. The kit was 
previously validated against a virus neutralization test 
(VNT) for analyzing reindeer serum samples for anti-
CvHV2 antibodies [26]. All serum samples were tested 
in duplicate and evaluated against bovine (provided with 
the kit) and reindeer [27] positive-control sera.
Results
Clinical signs
A thorough clinical examination, including body temper-
ature measurement, was conducted on each animal when 
they were physically or chemically immobilized, i.e. upon 
arrival to the fence, on the day of inoculation one month 
later (day 0), and on days 2, 5, 7, 13 and 15 p.i., as well as 
upon euthanasia, if euthanized outside this schedule.
Body temperature (n =  18) at the time of inoculation 
(day 0) varied from 37.8 to 39.5  °C (mean 39.0  °C, SD 
0.05). On day 5 p.i., the mean body temperature for all 
inoculated animals (except the controls) had increased 
to 39.8–40.6 °C (mean 40.2 °C), and decreased again over 
the following days. Mean temperature also increased 
for the control animals (n =  3), from 39.0  °C (day 0) to 
39.9  °C (day 7), after which it decreased to 39.6  °C (day 
10) and 39.3 °C (day 15).
In the CvHV2 group, no clinical signs were observed on 
day 1 (Table 1). On day 2, the inoculated eyes of all ani-
mals in this group displayed conjunctival oedema, four of 
the five animals having purulent exudate and two having 
hyperaemia of the conjunctiva (3). From day 3 to day 5, 
the severity of the oedema typically increased from mild 
(grade 1) to severe (grade 3), involving the whole perior-
bital region by day 5. Similarly, the suppuration increased 
from mild (grade 1) to severe (grade 3) (Fig.  2). Upon 
inspection on day 5, two animals (R5 and R10) were euth-
anized, showing corneal oedema, high grades of perior-
bital oedema and suppuration, as well as a slightly raised 
body temperature, 40.5 and 40.0 °C, respectively. Similar 
clinical signs were observed for R21 and R4, which were 
euthanized on day 6 and 7, respectively (Fig. 2). Animals 
R5 and R21 had at the time of euthanasia developed a 
corneal ulcer, by day 5 and day 6, respectively.
In the M. bovoculi group, a grey or whitish exudate 
was observed associated with the lower eyelid of the 
Fig. 2 Semi-domesticated Eurasian tundra reindeer (R21) experimen-
tally inoculated with reindeer alphaherpesvirus (cervid herpesvirus 2; 
CvHV2). a Day 0, i.e. the day of inoculation, b day 5 post inoculation 
(p.i.), and c day 6 p.i.
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inoculated right eye in two animals (R6 and R8) some 
hours after inoculation (day 0) and early the following day 
(day 1), which thereafter disappeared. No clinical signs 
were observed in this group throughout the remaining 
period of the experiment (Fig. 3).
The clinical signs observed in the group receiving both 
CvHV2 and M. bovoculi were indistinguishable from 
those described for the CvHV2 group (Table 1). All ani-
mals in this group, except the one euthanized on day 3 
(R17), showed suppuration and developed conjunctivitis, 
and corneal and periorbital oedema (Fig. 4). One animal 
(R1) developed a corneal ulcer.
No clinical signs of disease were recorded in the con-
trol animals (R2, R18, R20) throughout the experiment 
(day 0–15).
Bacteriology
On day 0, prior to inoculation, a few colonies of M. 
bovoculi were cultured from the conjunctiva of two ani-
mals (R6 and R8) from the group to be inoculated with 
M. bovoculi, and from another two animals (R1 and 
R17) from the group to be inoculated with CvHV2 and 
M. bovoculi. These isolates were all identified using the 
MALDI-TOF mass spectrometry. During the experi-
ment, M. bovoculi was, at different time points, cultivated 
from all five animals inoculated with the bacterium. In 
the group inoculated with CvHV2 and M. bovoculi, the 
bacterium was cultivated from three of five animals. In 
the group inoculated with CvHV2 alone, M. bovoculi 
was cultivated from four of five animals. No M. bovoculi 
was isolated from the control animals. In most cases, M. 
bovoculi was found with few colonies in a mixed culture.
PCR
In spite of being sero-negative, CvHV2-specific DNA was 
detected in one eye swab (nested PCR; R21) before the 
experiment, and this animal was allocated to the CvHV2 
group. No CvHV2-specific DNA was detected from con-
junctival swab samples from this animal or any other 
swab samples (both eyes, all animals) taken on day 0 of 
the experiment, i.e. prior to inoculation. Of the animals 
inoculated with CvHV2, alone or in combination with M. 
bovoculi, CvHV2 specific DNA was detected (qPCR) in 
all samples from both inoculated and control eyes, from 
day 2 until the last sampling of each animal (euthanasia). 
There were two exceptions: CvHV2 could not be detected 
in the swab sample from the right (inoculated) eye of 
animal R3 on day 5 (the day before euthanasia, though 
detected again upon euthanasia, day 6), nor from the left 
eye (not inoculated) of animal R21 on day 6 (the day of 
euthanasia).
From the animals inoculated with only M. bovoculi, 
CvHV2-specific DNA was detected in one sample from 
the left eye of animal R6 on day 6, but besides this, all 
samples from animals in this group and the control group 
were negative for CvHV2. Viral DNA was detected in the 
plasma of one animal (R7) from the CvHV2-inoculated 
group on day 2 but not in the plasma of this animal at 
later time points, and not from plasma samples from any 
other animal during the experiment.
Serology (CvHV2)
All animals selected for the study were sero-negative for 
CvHV2 upon arrival and on the day of inoculation (day 
0). Animals R21 and R4 from the group inoculated with 
Fig. 3 Semi-domesticated Eurasian tundra reindeer (R15) inoculated 
with Moraxella bovculi. a Day 0, i.e. the day of inoculation, b day 5 
post inoculation (p.i.), and c day 10 p.i.
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CvHV2 seroconverted on day 6 and 7, respectively, and 
animal R1 from the group inoculated with CvHV2 and 
M. bovoculi seroconverted on day 7.
Discussion
All animals inoculated with CvHV2, alone or in combina-
tion with M. bovoculi (Figs.  2 and 4) developed clinical 
signs characteristic of IKC [2, 4] with a quick onset (day 
2) and rapid progression from day 2 to days 5/6/7 (eutha-
nasia). The animals inoculated with M. bovoculi alone, 
and the control animals, remained healthy throughout 
the experiment. These unambiguous clinical results, gen-
erated from an experimental inoculation of one-year-old 
reindeer with all members of each animal group display-
ing similar responses, provide powerful support of pre-
vious findings during IKC outbreaks [4], that CvHV2 is 
capable of causing the clinical picture that is characteris-
tic for IKC in reindeer.
The titres of the inoculum of virus and bacteria in this 
study were probably high as compared to viral and bac-
terial transmissions under natural conditions, but nev-
ertheless, for the virus, in line with previous reported 
inoculations of BoHV1 in cattle [28]. It is, however, 
important to keep in mind that both the virus and the 
bacterium are replicative agents that, once the infection 
is established, will multiply in permissive cells, whereas 
virus and bacteria in excess will be washed away from the 
surface linings of the eye, rendering the inoculum titres 
less important.
We gently rubbed a part of the conjunctival mucosa of 
the lower eye lid to make sure that the infectious agents 
had access to permissive cells upon inoculation, but we 
chose not to conduct scarified corneal inoculations as 
has been done in similar experiments using cattle and 
Moraxella spp. [29]. The rubbing may be somewhat simi-
lar to what reindeer may experience when corralled and 
exposed to sand and dust in the pen. Thus, we think the 
conditions under which this experiment was carried out 
were in many ways close to a natural setting, including 
the fact that animals were young (<1  year) at the time 
of inoculation, and that they had been exposed to stress 
by being gathered from their mountain pastures, trans-
ported and corralled, and by being exposed to people and 
handling, all resembling natural herding conditions.
In IBK in cattle, the pathogenicity of M. bovis is based 
on the expression of a pilin protein for attachment [30] 
and a cytotoxin that damages the corneal epithelial cells 
[31]. However, M. bovoculi has also been associated with 
IBK. In a retrospective study of Moraxella spp. isolated 
from IBK outbreaks in 282 herds in 30 states of the USA, 
701 were identified as M. bovoculi and 295 isolates as M. 
bovis [32]. It has also been shown that M. bovoculi iso-
lates from cattle may have both putative cytotoxin [33] 
and pilin [34] genes, similar to those that have been iden-
tified in M. bovis. However, a randomized blind challenge 
study to assess the association between M. bovis and M. 
bovoculi, and IBK in 31 dairy calves, revealed that nine 
out of 10 calves inoculated with M. bovis developed cor-
neal ulcers consistent with IBK, whereas none of the 
10 calves inoculated with M. bovoculi did, although the 
authors stated that the pathogenicity of this particular M. 
bovoculi strain was not yet characterized [29]. This was 
also the situation for the M. bovoculi isolate used in our 
study, although it was originally isolated and identified as 
Fig. 4 Semi-domesticated Eurasian tundra reindeer (R1) inoculated 
with reindeer alphaherpesvirus (cervid herpesvirus 2; CvHV2) and 
Moraxella bovculi. a Day 0, i.e. the day of inoculation, b day 2 post 
inoculation (p.i.), and c day 5 p.i.
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the bacterium that was dominating the bacterial growth 
from a swab sample obtained from the conjunctiva of a 
reindeer with clinical signs of IKC. Large genetic differ-
ences have recently been reported between isolates of 
M. bovoculi from eyes of cattle with IBK as compared to 
isolates from the nasopharynx of asymptomatic cattle, 
suggesting that certain genetically distinct strains of M. 
bovoculi are associated with IBK in cattle [35], which may 
also be the case for IKC in reindeer.
Throughout our study period, M. bovoculi was culti-
vated from eight of 10 animals that had been inoculated 
with the bacterium alone or in combination with CvHV2, 
but no clinical signs were associated with these findings 
in those inoculated with M. bovoculi alone. This might 
indicate that the isolate of M. bovoculi used for inocula-
tion was not pathogenic, or that the duration of the bac-
terial infection was too short to produce clinical signs. 
M. bovoculi was also cultivated from four animals prior 
to inoculation (day 0), and from four animals inoculated 
with CvHV2 alone, from the right eye of all four animals 
and from both eyes of one individual. This may indicate 
the transmission of bacteria from other individuals, which 
means that M. bovoculi was transferred from inoculated 
animals into the other corrals. However, the fact that M. 
bovoculi was not cultivated from any of the control ani-
mals at any time (day 0–day 13 p.i.) indicated that M. 
bovoculi was not introduced but rather sporadically pre-
sent in apparently healthy reindeer without ocular dis-
ease. The bacterium may therefore be a commensal in the 
conjunctiva of reindeer as also indicated from previous 
bacteriological screenings [17]. Since serology for anti-
bodies against M. bovoculi prior to the inoculation was 
not conducted, it can be argued that a lack of clinical signs 
in the animals inoculated with M. bovoculi alone may be 
due to a pre-existing immunity against the bacterium, 
but it remains uncertain if presence of the bacterium on 
mucosal membranes such as conjunctiva and nasophar-
ynx would elicit a detectable humoral immune response.
Animals R1 (CvHV2 and M. bovoculi), and R4 and R21 
(CvHV2) had antibodies against CvHV2 on the day of 
euthanasia (day 6 and 7, respectively), whereas the other 
animals inoculated with CvHV2 assumingly were eutha-
nized prior to sero-conversion. This is in line with pre-
vious inoculation experiments in reindeer with CvHV2 
[36], in which a humoral immune response generally was 
not evident until days 8–10 p.i. Thus, the rapid onset of 
clinical signs after inoculation of CvHV2 in the conjunc-
tiva indicates that a primary specific immune response 
will develop too late to be protective against disease in 
previously unexposed animals. This, and the observation 
that the seroprevalence among reindeer aged <1 year in 
Finnmark County, Norway, was only 8% as compared to 
77% in adults (2004–2006) [26] suggests a rapid spread of 
the virus among young and immunologically naïve ani-
mals, sometimes resulting in outbreaks of IKC involving 
hundreds of animals [1, 18]. The hypothesis that stress 
causes reactivation of CvHV2 in latently infected animals 
[37] with subsequent viral shedding, exposing young and 
immunologically naïve animals to the virus, seems to be 
valid. During later stages of the disease, however, many 
different bacterial species, including M. bovoculi, have 
been isolated, but their role may be of a more opportun-
istic character, establishing infection and possibly being 
pathogenic once the mucosa is impacted by the CvHV2 
infection. Based on the recent reports of the pathogenic 
properties of M. bovoculi in cattle, the pathogenic poten-
tial of the M. bovoculi isolates from reindeer should be 
further investigated.
No clinical signs were recorded in the three control 
animals, or in the left eye (control) of the inoculated 
reindeer (all groups). This lack of clinical signs in the left 
(control) eyes is in contrast to the detection of CvHV2-
specific DNA from the left eyes of all CvHV2-inoculated 
animals from day 2 until the last sampling day, with the 
exceptions of animal R21 on day 6. At the same time, we 
were also unable to demonstrate viremia, since CvHV2-
specific DNA was detected in a plasma sample from only 
one animal (R7) at one time point (day 2) during the 
experiment. Thus, these results indicate that the virus 
was able to spread from the inoculated conjunctiva to the 
conjunctival mucosa of the other eye within 2 days p.i. in 
all CvHV2- inoculated animals,
Conclusions
Experimental inoculation of semi-domesticated reindeer 
revealed that CvHV2 is capable of inducing typical clini-
cal signs of IKC within 2–7 days p.i., suggesting that the 
reindeer alphaherpesvirus, CvHV2, is the transmissible 
and causative agent of IKC in reindeer. The combined 
inoculation of CvHV2 and M. bovoculi did not change the 
onset, development, or the character of the clinical signs. 
Ocular inoculation of M. bovoculi alone did not produce 
clinical signs. M. bovoculi and other bacteria may, how-
ever, be important as opportunistic pathogens, especially 
during later stages of the disease.  Based on the recent 
reports of the pathogenic properties of M. bovoculi in 
cattle [35, 38], the pathogenic potential of the M. bovoculi 
isolates from reindeer should be further investigated.
Authors’ contributions
MT, TDJ and TM designed the study. MT, JSR, NM, IHN, KKS, TDJ, and TM con-
ducted the preparations, experiment and sampling. TDJ and TM conducted 
the necropsy of animals and further sampling. The laboratory analyses were 
conducted by JSR, NM, IHN and KKS. MT drafted the manuscript. All authors 
contributed to the manuscript and approved the final version. All authors read 
and approved the final manuscript.
Page 10 of 11Tryland et al. Acta Vet Scand  (2017) 59:23 
Author details
1 Arctic Infection Biology, Department of Arctic and Marine Biology, UiT-The 
Arctic University of Norway, POBox 6050, Langnes, 9037 Tromsø, Norway. 
2 Norwegian Veterinary Institute, POBox 6050, Langnes, 9037 Tromsø, Norway. 
3 Vascular Biology Research Group, Department of Medical Biology, Faculty 
of Health Sciences, UiT-The Arctic University of Norway, Tromsø, Norway. 
4 Present Address: Clinique vétérinaire de l’abbatiale, 14 bis Rue Thibaut, 
52220 Montier En Der, France. 5 Present Address: Faculty of Bioscience 
and Aquaculture, Nord University, Bodø, Norway. 
Acknowledgements
We thank reindeer herders for their help and patience when working with 
their herd during selection of experimental animals. We also thank the 
veterinary students Ole Christian Kjenstad and Pauline Birgitte Ulvig Kiær (Nor-
wegian University of Life Sciences) and Trygve Vik and Jørg Vik for help during 
the experiments, as well as Eva Marie Breines, Ellinor Hareide (UiT-The Arctic 
University of Norway) and Karin-Elisabeth Holmgren (Norwegian Veterinary 
Institute, Tromsø, Norway) for excellent help in the laboratory. Marianne Sunde 
(Norwegian Veterinary Institute, Oslo, Norway) is acknowledged for conduct-
ing the 16S rRNA and the MALDI-TOF mass spectrometry on the M. bovculi 
isolates. Sophie Scotter, UiT-Arctic University of Norway, is acknowledged for 
language corrections.
Competing interests
The authors declare that they have no competing interests.
Availability of data and materials
The datasets used and/or analysed during the current study are available from 
the corresponding author on reasonable request.
Ethics approval and consent to participate
The study followed the Guiding Principles for Biomedical Research Involving 
Animals developed by the Council for International Organizations of Medical 
Sciences (CIOMS). The motivation for the study was based on the need to 
identify the transmissible and causative agent of IKC in semi-domesticated 
reindeer to better understand the pathogenesis and to improve prophylaxis 
and medical treatment during disease outbreaks. The study was approved by 
the Norwegian Animal Research Authority (NARA; application ID 5880).
Funding
The study was funded by grants from the Norwegian Reindeer Development 
Fund (RUF) and Nordic Council of Ministers (NORDREGIO). The publication 
charges for this article have been funded by a grant from the publication fund 
of UiT The Arctic University of Norway.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in pub-
lished maps and institutional affiliations.
Received: 27 January 2017   Accepted: 19 April 2017
References
 1. Bergman A. Contagious keratitis in reindeer. Scand Vet J. 1912;2:145–77.
 2. Rehbinder C, Nilsson A. An outbreak of kerato-conjunctivitis among cor-
ralled, supplementary fed, semi-domesticated reindeer calves. Rangifer. 
1995;15:9–14.
 3. Oksanen A. Keratoconjunctivitis in a corralled reindeer. Proceedings of 
the seventh Nordic Workshop on Reindeer Research. Rangifer Report. 
1993;1:50.
 4. Tryland M, das Neves CG, Sunde M, Mørk T. Cervid herpesvirus 2 the 
primary agent in an outbreak of infectious keratoconjunctivitis in semi-
domesticated reindeer. J Clin Microbiol. 2009;47:3707–13. doi:10.1128/
JCM.01198-09.
 5. Angelos JA. Infectious bovine keratoconjunctivitis (pinkeye). Vet Clin 
North Am Food Anim Pract. 2015;31:61–79.
 6. Angelos JA, Spinks PQ, Ball LM, George LW. Moraxella bovoculi sp. nov., 
isolated from calves with infectious bovine keratoconjunctivitis. Int J Syst 
Evol Microbiol. 2007;57:789–95.
 7. Angelos JA. Moraxella bovoculi and infectious bovine keratoconjunctivitis: 
cause or coincidence? Vet Clin North Am Food Anim Pract. 2010;26:73–8. 
doi:10.1016/j.cvfa.2009.10.002.
 8. Åkerstedt J, Hofshagen M. Bacteriological investigation of infectious 
keratoconjunctivitis in Norwegian sheep. Acta Vet Scand. 2004;45:19–26.
 9. Gupta S, Chahota R, Bhardwaj B, Malik P, Verma S, Sharma M. Identifica-
tion of Chlamydia and Mycoplasma species in ruminants with ocular 
infections. Lett Appl Microbiol. 2015;60:135–9. doi:10.1111/lam.12362.
 10. Dubay SA, Williams ES, Mills K, Boerger-Fields AM. Association of Moraxella 
ovis with keratoconjunctivitis in mule deer and moose in Wyoming. J 
Wildl Dis. 2000;36:241–7.
 11. Giacometti M, Janovsky M, Belloy L, Frey J. Infectious keratoconjunctivitis 
of ibex, chamois and other caprinae. Rev Sci Tech. 2002;21:335–45.
 12. Gortázar C, Fernández-de-Luco D, Frölich K. Keratoconjunctivitis in a 
free-ranging red deer (Cervus elaphus) population in Spain. Z Jagdwiss. 
1998;44:257–61.
 13. Mavrot F, Vilei EM, Marreros N, Signer C, Frey J, Ryser-Degiorgis MP. Occur-
rence, quantification and genotyping of Mycoplasma conjunctivae in wild 
Caprinae with and without infectious keratoconjunctivitis. J Wildl Dis. 
2012;48:619–31.
 14. Grymer J. Infektiøs bovin keratokonjunktivitis hos kvæg og rådyr. Dansk 
Vet Tidsskr. 1984;67:854–6.
 15. Kummeneje K. Isolation of Neisseria ovis and a Colesiota conjunctivae-like 
organism from cases of kerato-conjunctivitis in reindeer in northern 
Norway. Acta Vet Scand. 1976;17:107–8.
 16. Aschfalk A, Josefsen TD, Steingass H, Müller W, Goethe R. Crowding and 
winter emergency feeding as predisposing factors for kerato-conjunctivi-
tis in semi-domesticated reindeer in Norway. Dtsch Tierarztl Wochenschr. 
2003;110:295–8.
 17. Sanchez Romano J, Marcin N, Josefsen TD, Nymo IH, Sørensen KK, Tryland 
M. Severe transmissible eye infection in reindeer: bacterium or virus? 
64th Annual International Conference of the Wildlife Disease Association, 
Queensland; 2015. p. 26–30 (abstract 45, page 13).
 18. Skjenneberg S, Slagsvold L. Reindriften og dens naturgrunnlag. Oslo: 
Universitetsforlaget; 1968.
 19. Tryland M, Stubsjøen SM, Ågren E, Johansen B, Kielland C. Herding condi-
tions related to infectious keratoconjunctivitis (IKC) in semi-domesticated 
reindeer (Rangifer t. tarandus) in Norway and Sweden—a questionnaire-
based survey among reindeer herders. Acta Vet Scand. 2016;58:22. 
doi:10.1186/s13028-016-0203-x.
 20. Ryeng KA, Arnemo JM, Larsen S. Determination of optimal immobilizing 
doses of a medetomidine hydrochloride and ketamine hydrochloride 
combination in captive reindeer. Am J Vet Res. 2001;62:119–26.
 21. Ros C, Belak S. Studies of genetic relationships between bovine, caprine, cer-
vine, and rangiferine alphaherpesviruses and improved molecular methods 
for virus detection and identification. J Clin Microbiol. 1999;37:1247–53.
 22. Ros C, Belak S. Characterization of the glycoprotein B gene from ruminant 
alphaherpesviruses. Virus Genes. 2002;24:99–105.
 23. Ek-Kommonen C, Pelkonen S, Nettleton PF. Isolation of a herpesvirus 
serologically related to bovine herpesvirus 1 from a reindeer (Rangifer 
tarandus). Acta Vet Scand. 1986;27:299–301.
 24. Miller JM, van der Maaten MJ. Reproductive tract lesions in heifers after 
intrauterine inoculation with infectious bovine rhinotracheitis virus. Am J 
Vet Res. 1984;45:790–4.
 25. Wang J, O’Keefe J, Orr D, Loth L, Banks M, Wakeley P, West D, Card R, 
Ibata G, Van Maanen K, Thoren P, Isaksson M, Kerkhofs P. Validation of a 
real-time PCR assay for the detection of bovine herpesvirus 1 in bovine 
semen. J Virol Meth. 2007;144:103–8.
 26. Das Neves CG, Roger M, Yoccoz NG, Rimstad E, Tryland M. Evaluation of 
three commercial bovine ELISA kits for detection of antibodies against 
alphaherpesviruses in reindeer (Rangifer tarandus tarandus). Acta Vet 
Scand. 2009;51:9. doi:10.1186/1751-0147-51-9.
 27. Das Neves CG, Thiry J, Skjerve E, Yoccoz N, Rimstad E, Thiry E, Tryland M. 
Alphaherpesvirus infections in semidomesticated reindeer: a cross-
sectional serological study. Vet Microbiol. 2009;139:262–9. doi:10.1016/j.
vetmic.2009/06.013.
Page 11 of 11Tryland et al. Acta Vet Scand  (2017) 59:23 
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
 28. Marin MS, Leunda MR, Verna AE, Morán PE, Odeón AC, Pérez SE. 
Distribution of bovine herpesvirus type 1 in the nervous system of 
experimentally infected calves. Vet J. 2016;209:82–6. doi:10.1016/j.
tvjl.2015.10.034.
 29. Gould S, Dewell R, Tofflemire K, Whitley RD, Millman ST, Opriessnig T, 
Rosenbusch R, Trujillo J, O`Connor AM. Randomized blinded challenge 
study to assess association between Moraxella bovoculi and Infectious 
Bovine Keratoconjunctivitis in dairy calves. Vet Microbiol. 2013;164(1–
2):108–15. doi:10.1016/j.vetmic.2013.01.038.
 30. Jayappa HG, Lehr C. Pathogenicity and immunogenicity of piliated 
and nonpili-ated phases of Moraxella bovis in calves. Am J Vet Res. 
1986;47:2217–21.
 31. Rogers DG, Cheville NF, Pugh GW Jr. Pathogenesis of corneal 
lesions caused by Moraxella bovis in gnotobiotic calves. Vet Pathol. 
1987;24:287–95.
 32. Loy JD, Brodersen BW. Moraxella spp. isolated from field outbreaks 
of infectious keratoconjunctivitis: a retrospective study of case 
submissions from to 2013. J Vet Diagn Invest. 2010;2014(26):761–8. 
doi:10.1177/1040638714551403.
 33. Angelos JA, Ball LM, Hess JF. Identification and characterization of com-
plete RTX operons in Moraxella bovoculi and Moraxella ovis. Vet Microbiol. 
2007;125:73–9.
 34. Calcutt MJ, Foecking MF, Martin NT, Mhlanga-Mutangadura T, Reilly TJ. 
Draft genome sequence of Moraxella bovoculi strain 237T (ATCC BAA-
1259T) isolated from a calf with infectious bovine keratoconjunctivitis. 
Genome Announc. 2014;2:e00612–4. doi:10.1128/genomeA.00612-14.
 35. Dickey AM, Loy JD, Bono JL, Smith TPL, Apley MD, Lubbers BV, DeDonder 
KD, Capik SF, Larson RL, White BJ, Blom J, Chitko-McKown CG, Clawson 
ML. Large genomic differences between Moraxella bovoculi isolates 
acquired from the eyes of cattle with infectious bovine keratoconjunc-
tivitis versus the deep nasopharynx of asymptomatic cattle. Vet Res. 
2016;47:31. doi:10.1186/s13567-016-0316-2.
 36. Das Neves CG, Mørk T, Godfroid J, Sørensen KK, Breines E, Hareide E, 
Thiry J, Rimstad E, Thiry E, Tryland M. Experimental infection of reindeer 
with cervid herpesvirus 2. Clin Vaccine Immunol. 2009;16:1758–65. 
doi:10.1128/CVI.00218-09.
 37. Das Neves CG, Mørk T, Thiry J, Godfroid J, Rimstad E, Thiry E, Tryland 
M. Cervid herpesvirus 2 experimentally reactivated in reindeer can 
produce generalized viremia and abortion. Virus Res. 2009;145:321–8. 
doi:10.1016/j.virusres.2009.08.002.
 38. O’Connor AM, Shen HG, Wang C, Opriesnig T. Descriptive epidemiology 
of Moraxella bovis, Moraxella bovoculi and Moraxella ovis in beef calves 
with naturally occuring infectious bovine keratoconjunctivitis (pinkeye). 
Vet Microbiol. 2012;155:374–80.
